VCL and measles: Vaccine recipients typically have GMCs of measles neutralizing antibodies below 5000 mIU/mL while vaccinated individuals recently exposed to wild-type MV may develop concentrations of anti-measles neutralizing antibodies ≥40,000 mIU/mL [16].